Commissioner highlights obstacles to innovation
This article was originally published in Clinica
Enterprises working with novel biotechnologies do not know if they are fully allowed to reap the commercial benefits of their work." That was one of the key concerns expressed by European Commissioner in charge of research, Philippe Busquin, when he addressed the general assembly of the European biotechnology trade association, EuropaBio, on June 24.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.